The Role of PET in Staging Non-Small Cell Lung Cancer / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 481-485, 2004.
Artigo
em Coreano
| WPRIM
| ID: wpr-203802
ABSTRACT
Lung cancer has become a leading cause of cancer death in Korea. Accurate staging of non-small cell lung cancer (NSCLC) is essential to the ability to offer a patient the most effective available treatment and the best estimate of prognosis. PET with F-18 fluorodeoxyglucose (FDG) is indicated for the nodal staging of NSCLC and detection of distant metastases. Use of PET for mediastinal staging should not be relied on as a sole staging modality, and positive findings should be confirmed by mediastinoscopy. FDG PET avoids futile surgery by a more accurate selection of patients, especially by the detection of unexpected distant metastases.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Prognóstico
/
Carcinoma Pulmonar de Células não Pequenas
/
Coreia (Geográfico)
/
Neoplasias Pulmonares
/
Mediastinoscopia
/
Metástase Neoplásica
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
País/Região como assunto:
Ásia
Idioma:
Coreano
Revista:
Korean Journal of Nuclear Medicine
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS